Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy.
Tu MM, Abdel-Hafiz HA, Jones RT, Jean A, Hoff KJ, Duex JE, Chauca-Diaz A, Costello JC, Dancik GM, Tamburini BAJ, Czerniak B, Kaye J, Theodorescu D.
Tu MM, et al. Among authors: dancik gm.
Commun Biol. 2020 Nov 27;3(1):720. doi: 10.1038/s42003-020-01441-y.
Commun Biol. 2020.
PMID: 33247183
Free PMC article.